PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: NeonDrum Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Publishing Technology to Build New Digital Platform for the American Society for Microbiology - Deal sees the creation of a next-generation digital platform to host all of the organization’s published authoritative content online - PublishingTechnology.com
Publishing Technology to Build New Digital Platform for the American Society for Microbiology

 

NewswireToday - /newswire/ - Cambridge, MA, United States, 2011/12/15 - Deal sees the creation of a next-generation digital platform to host all of the organization’s published authoritative content online - PublishingTechnology.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The American Society for Microbiology (ASM) and Publishing Technology plc (LSE: PTO) today announced a partnership to create a next-generation digital platform to host all of the organization’s published authoritative content online.

The new custom-built site, which will be developed on Publishing Technology’s pub2web platform, will house the largest single collection of microbiology research available, including ASM’s journal titles dating back to 1916, its news magazine Microbe, a rapidly expanding image library, 240 book titles and a range of individual reports, articles and videos - all in one single aggregated site.

By maximizing the digital opportunities available, ASM will be able to offer its community of scientists, clinicians, authors and librarians a flexible and user-friendly online experience via pub2web’s semantic technology offering tagging and faceted search. It will enable visitors to search, browse and discover ASM content quickly and effectively. ASM will in turn benefit from a more flexible and sophisticated platform that will allow it to experiment with new business models, new functionality and new formats of delivery.

ASM is a long-standing customer of Publishing Technology sales and marketing consulting firm Publishers Communication Group (PCG), who continue to provide sales representation for the Society’s diverse content around the world. Additionally, the new ASM site design will be focus-group tested through PCG-conducted market research.

“This strategic partnership expands upon our established relationship with Publishers Communication Group and will completely revamp our online offerings,” said Dr. David Hooper, ASM President. “The new project promises to be cutting edge, allowing our stakeholders to access our entire library with ease. We look forward to working closely with Publishing Technology to launch the site in the near future.”

”We are delighted to be working with ASM on this exciting project,” said George Lossius, CEO of Publishing Technology. “By combining the strength of our pub2web platform with the expertise of our marketing and sales consultancy division PCG we are able to provide cutting edge technology plus practical guidance on forecasting content sales, the roll out of new business models and focus groups to ensure that the new platform is tailored to the needs of the microbiology community. With such a diverse range of content sources being made accessible, searchable and discoverable in one single place, the ASM website will become the new online home of all things microbiology.”

For more information, please contact:
Michael Groth, Publishing Technology plc
T: +1 617 395 4089

About Publishing Technology plc
Publishing Technology’s products and services include advance, ingentaconnect, VISTA, author2reader, pub2web, ICS and PCG. The Publishing Technology group (publishingtechnology.com) enables publishers to focus on their core competences by providing a single, trusted partner for both technology requirements and business development services. It is one of the largest providers of software and services for the publishing industry, servicing eight out of ten of the world's largest publishers. The group’s proposition uniquely spans front and back office systems – complemented by a range of business development services – to provide the industry's only end-to-end suite of software specifically designed to support the publishing process. Capabilities cover editorial & production, product information, billing & fulfillment, content conversion & hosting, website development, marketing programs, information commerce, customer relationship management, rights & royalties and business intelligence. All application modules can be configured independently to meet specific publishers' needs and to allow flexible integration with existing systems. Associated sales and marketing services include consultancy and research, sales representation and telemarketing. The company is listed on the AIM market of the London Stock Exchange and has offices in the UK, US, Brazil, India, China and Australia.

About pub2web
The pub2web platform is a customized, multi-content publications portal—delivering all the functionality needed to support evolving online strategies and to satisfy the user base, however diverse their needs. Customers benefit from proven, regularly-updated technology while also maintaining full control of their brand, their content and their user relationships. It allows customers to help their users to explore all their content – whatever its format – with progressive browsing options driven by pub2web’s award-winning data storage and modeling.

Follow on Twitter @publishingtech, or connect on LinkedIn.

About ASM
The American Society for Microbiology is the world's largest scientific society of individuals interested in the microbiological sciences. The mission of the American Society for Microbiology is to advance the microbiological sciences as a vehicle for understanding life processes and to apply and communicate this knowledge for the improvement of health and environmental and economic well-being worldwide. A leader in society publishing with over 90 years of experience, ASM journals continue to advance the full spectrum of basic and clinical microbiology research, delivering cutting-edge science to researchers across the globe. ASM journals publish nearly a quarter of all microbiology articles, while accounting for over 38% of all citations in microbiology. ASM Press publishes a broad selection of texts, references, monographs, and general interest titles in the microbiological sciences that are used as the foundational texts in colleges and universities and as reference materials in laboratories around the world. Showcasing internationally renowned authors and editors with expertise in a broad range of disciplines, ASM Press titles have been translated into more than a dozen languages.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: NeonDrum Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Publishing Technology to Build New Digital Platform for the American Society for Microbiology

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Liz Hartney - NeonDrum.com 
+44(0)75 1051 8732 michael.groth[.]publishingtechnology.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any NeonDrum Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From NeonDrum Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis
BTG and HealthLoop Collaborate on IO Loop™ - An Exclusive Service to Connect Patients and Interventional Oncologists throughout Treatment
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
MDxHealth and Maastricht University Collaborate on Next Generation (Epi)genetic Cancer Diagnostics
BD to Invest $60 Million in Nebraska Manufacturing Facility
MDxHealth Announces New Contract with MediNcrease Health Plans Regarding ConfirmMDx and SelectMDx
Pulse Certified As A Level Four Multichannel Content Agency by Veeva
Earthly Mist - Opioid-Alternative Painkiller, Kratom Now Available in Oklahoma City
MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit MagLar, Inc.

Visit  Deb Sheppard - Medium Psychic Author Speaker





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)